The US could substantially slash tariffs on Indian exports as the two countries near a trade deal that could see New Delhi cutting oil purchases from Russia, according to reports
S&P Global report states that two-thirds of the total additional cost will be passed on to the consumers via higher prices, while one-third ($315 billion) is absorbed internally through lower earnings
India is aiming for a 15 per cent tariff under a trade deal with Washington that will make its labour intensive shipments to the US cheaper compared to its Asian peers
Global trade dynamics are shifting. India may have to make some concessions in agriculture but will likely gain in manufacturing and defense, Shenoy said
Just as domestic investors aren't married to one stock forever, foreign investors too assess all markets and make tactical shifts, says Ambani
DFS secy to meet PSBs to assess credit flow
Amid US-China trade tensions and economic vulnerabilities, India must seize the "China +1" opportunity, deepen reforms, secure FTAs, and globalise its firms for long-term growth
Sensex Today | Stock Market close, October 8, 2025: In the broader market, the Nifty Midcap 100 and Smallcap 100 indices slipped 0.73 per cent and 0.52 per cent, respectively.
Sensex Today | Stock Market close, October 7, 2025: In the broader markets, the Nifty Midcap 100 index rose 0.47 per cent, and the Nifty Smallcap 100 index rose 0.31 per cent
The upward revision in RBI's FY26 growth forecast signals strong confidence in India's domestic economic momentum which has consistently beaten expectations
Sensex Today | Stock Market close highlights: In the broader markets, the Nifty Midcap 100 and Nifty Smallcap 100 indices were trading higher by 0.89 per cent and 0.28 per cent, respectively
The selling pressure on the counter came after the company informed that it continued to experience a slowdown in revenues in the September quarter (Q2FY26)
The Directorate General of Foreign Trade has extended the RoDTEP scheme till March 2026, ensuring policy continuity for exporters navigating US tariff hikes and global headwinds
The net profit margins of US listed companies in tradeable goods averaged around 12 per cent last year, more than double the 4.9 per cent of their Chinese peers
Today's pieces look at the available space for more rate cuts, the sorry state of tribunals, why GST reforms are not really that, and how India can harness its vast non-export MSME sector
Commerce Secretary Howard Lutnick has said that the US will have to fix countries like Brazil and India, asserting that these nations need to react correctly to America by opening their markets and refraining from actions that could harm American interests. The Trump administration has imposed 50 per cent tariffs on India, including a 25 per cent tariff on New Delhi's purchases of Russian oil, among the highest tariff rates imposed on any country in the world. "We have a bunch of countries to fix, like Switzerland, Brazil, India - these are countries that need to really react correctly to America. Open their markets, stop taking actions that harm America, and that's why we're off sides with them," Lutnick said in an interview with NewsNation. Lutnick said that these countries have to understand that if "you want to sell to the US consumers, you've got to play ball with the President of the United States." Apart from India and Brazil, Lutnick also mentioned countries like Taiwan and
The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report. The US last week announced the imposition of a 100 per cent tariff on branded or patented drugs entering the United States from October 1, except for pharmaceutical companies building manufacturing plants in the US. The exemption covers projects where construction has started, including sites that have broken ground or are under construction. HSBC said Sun Pharma reported global sales of USD 1.217 billion from patented products in FY25, of which the US market accounted for about USD 1.1 billion (85-90 per cent of global sales),
This is a concern for Singapore as pharmaceuticals form around 13% of all Singapore exports to the U.S., said Gan
Nomura's top picks in the current tariff scenario include ICICI Bank (Buy), State Bank of India (SBI) (Buy), and Axis Bank (Buy)
US Customs as started a formal investigation of Waaree and Waaree Solar Americas Inc over suspected evasion of anti-dumping duties, imposing interim measures on solar imports